deltatrials
Unknown OBSERVATIONAL NCT05558046

Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique

Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Updated 4 times since 2022 Last updated: Sep 24, 2022 Started: Oct 1, 2022 Primary completion: Mar 1, 2023 Completion: Jun 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates DNA Damage and Granulosa Cells and is currently ongoing. Zeynep Kamil Maternity and Pediatric Research and Training Hospital leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotNot Yet Recruiting~Oct 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Oct 2024 — Present [monthly]

    Unknown

    Status: Not Yet RecruitingUnknown

  2. Sep 2024 — Oct 2024 [monthly]

    Not Yet Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

  4. Sep 2022 — Jul 2024 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Data source: Zeynep Kamil Maternity and Pediatric Research and Training Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.